David J. Albers

David J. Albers

Auto-generated profile, based on publicly available information

David J. Albers

Department of Bioengineering, University of Colorado Anschutz, 12705 E Montview Blvd Suite 100, CO 80045, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AWAshenafi Zebene Woldaregay
Ashenafi Zebene Woldaregay
EÅEirik Årsand
Eirik Årsand
TBTaxiarchis Botsis
Taxiarchis Botsis
DADavid Albers
David Albers
LMLena Mamykina
Lena Mamykina
GHGunnar Hartvigsen
Gunnar Hartvigsen
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Diabetes mellitus is a chronic metabolic disorder that results in abnormal blood glucose regulations. Blood glucose level is preferably maintained close to normality through self-management practices, which involves actively tracking blood glucose levels and taking proper actions including adjusting diet and insulin medications. Blood glucose anomalies could be defined as any undesirable reading either due to a precisely known reason (normal cause variation) or unknown reason (special cause variation) to the patient. Recently, machine learning applications have been widely introduced within the diabetes research in general and blood glucose anomalies detection in particular. However, irrespective of their expanding and increasing popularity, there is lack of updated reviews that materialize the current trends in modelling options and strategies for blood glucose anomalies classification and detection in people with diabetes. Objective: The objective of this review is to identify, assess and analyze the state-of-the-art machine learning strategies and its hybrid systems focusing on blood glucose anomalies classification and detection including glycemic variability, hyperglycemia, and hypoglycemia in type 1 diabetes within the context of personalized decision support systems and blood glucose alarm events applications, which are important constituents for optimal diabetes self-management. Methods: A rigorous literature was conducted between September 1 and October 1, 2017, through various online databases including Google scholar, PubMed, ScienceDirect and others. Peer reviewed journals and articles were considered. Relevant articles were first identified by reviewing the title, keywords, and abstracts as a preliminary filter with our selection criteria, and then reviewed the full text articles that fulfilled the inclusion criteria. Information from the selected literature was extracted based on some predefined categories, which were based on previous research and further elaborated through brainstorming. Results: The initial hit was vetted using the title, abstract, and keywords, and retrieved a total of 496 papers. After a thorough assessment and screening 47 articles were left, which were critically analyzed. The inter-rater agreement was measured using Cohen Kappa test, and disagreements were resolved through discussion. The state-of-the-art classes of machine learning have been developed and tested up to the task and achieved promising performance including artificial neural network, support vector machine, decision tree, genetic algorithm, Gaussian process regression, Bayesian neural network, deep belief network, and others. Conclusions: Despite the complexity of blood glucose dynamics, there are many attempts to capture hypoglycemia, hyperglycemia incidences and the extent of an individual’s glycemic variability using different approaches. Recently, advancement of diabetes technologies and continuous accumulation of self-collected health data has paved the way for popularity of machine learning in these tasks. According to the review, most of the identified studies used a theoretical threshold, which suffers from inter and intra-patient variation. Therefore, future studies should consider the difference among patients and also track its temporal change overtime. Moreover, studies should also give more emphasis on the types of inputs used and its associated time lag. Generally, we foresee these developments might encourage researchers to further develop and test these systems on a large-scale basis.

1 May 2020 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
LFLi-Heng Fu
Li-Heng Fu
JSJessica Schwartz
Jessica Schwartz
AMAmanda Moy
Amanda Moy
CKChris Knaplund
Chris Knaplund
MKMin-Jeoung Kang
Min-Jeoung Kang
SRSarah Collins Rossetti
Sarah Collins Rossetti

23 July 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
DRDavid J. Roh
David J. Roh
DADavid J. Albers
David J. Albers
JMJessica Magid-Bernstein
Jessica Magid-Bernstein
KDKevin Doyle
Kevin Doyle
EHEldad Hod
Eldad Hod
JCJan Claassen
Jan Claassen
Objective Studies have independently shown associations of lower hemoglobin levels with larger admission intracerebral hemorrhage (ICH) volumes and worse outcomes. We investigated whether lower admission hemoglobin levels are associated with more hematoma expansion (HE) after ICH and whether this mediates lower hemoglobin levels9 association with worse outcomes. Methods Consecutive patients enrolled between 2009 and 2016 to a single-center prospective ICH cohort study with admission hemoglobin and neuroimaging data to calculate HE (>33% or >6 mL) were evaluated. The association of admission hemoglobin levels with HE and poor clinical outcomes using modified Rankin Scale (mRS 4–6) were assessed using separate multivariable logistic regression models. Mediation analysis investigated causal associations among hemoglobin, HE, and outcome. Results Of 256 patients with ICH meeting inclusion criteria, 63 (25%) had HE. Lower hemoglobin levels were associated with increased odds of HE (odds ratio [OR] 0.80 per 1.0 g/dL change of hemoglobin; 95% confidence interval [CI] 0.67–0.97) after adjusting for previously identified covariates of HE (admission hematoma volume, antithrombotic medication use, symptom onset to admission CT time) and hemoglobin (age, sex). Lower hemoglobin was also associated with worse 3-month outcomes (OR 0.76 per 1.0 g/dL change of hemoglobin; 95% CI 0.62–0.94) after adjusting for ICH score. Mediation analysis revealed that associations of lower hemoglobin with poor outcomes were mediated by HE (p = 0.01). Conclusions Further work is required to replicate the associations of lower admission hemoglobin levels with increased odds of HE mediating worse outcomes after ICH. If confirmed, an investigation into whether hemoglobin levels can be a modifiable target of treatment to improve ICH outcomes may be warranted.

21 August 2019 in Inverse Problems
Verified
Journal Article
Closed access
PDF file
DADavid J Albers
David J Albers
PBPaul-Adrien Blancquart
Paul-Adrien Blancquart
MLMatthew E Levine
Matthew E Levine
ESElnaz Seylabi
Elnaz Seylabi
ASAndrew M Stuart
Andrew M Stuart
Ensemble Kalman methods constitute an increasingly important tool in both state and parameter estimation problems. Their popularity stems from the derivative-free nature of the methodology which may be readily applied when computer code is available for the underlying state-space dynamics (for state estimation) or for the parameter-to-observable map (for parameter estimation). There are many applications in which it is desirable to enforce prior information in the form of equality or inequality constraints on the state or parameter. This paper establishes a general framework for doing so, describing a widely applicable methodology, a theory which justifies the methodology, and a set of numerical experiments exemplifying it.

24 February 2021 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
SRSarah Collins Rossetti
Sarah Collins Rossetti
CKChris Knaplund
Chris Knaplund
DADave Albers
Dave Albers
PDPatricia C Dykes
Patricia C Dykes
MKMin Jeoung Kang
Min Jeoung Kang
KCKenrick Cato
Kenrick Cato
Objective: There are signals of clinicians’ expert and knowledge-driven behaviors within clinical information systems (CIS) that can be exploited to support clinical prediction. Describe development of the Healthcare Process Modeling Framework to Phenotype Clinician Behaviors for Exploiting the Signal Gain of Clinical Expertise (HPM-ExpertSignals).Materials and Methods: We employed an iterative framework development approach that combined data-driven modeling and simulation testing to define and refine a process for phenotyping clinician behaviors. Our framework was developed and evaluated based on the Communicating Narrative Concerns Entered by Registered Nurses (CONCERN) predictive model to detect and leverage signals of clinician expertise for prediction of patient trajectories.Results: Seven themes—identified during development and simulation testing of the CONCERN model—informed framework development. The HPM-ExpertSignals conceptual framework includes a 3-step modeling technique: (1) identify patterns of clinical behaviors from user interaction with CIS; (2) interpret patterns as proxies of an individual’s decisions, knowledge, and expertise; and (3) use patterns in predictive models for associations with outcomes. The CONCERN model differentiated at risk patients earlier than other early warning scores, lending confidence to the HPM-ExpertSignals framework.Discussion: The HPM-ExpertSignals framework moves beyond transactional data analytics to model clinical knowledge, decision making, and CIS interactions, which can support predictive modeling with a focus on the rapid and frequent patient surveillance cycle.Conclusions: We propose this framework as an approach to embed clinicians’ knowledge-driven behaviors in predictions and inferences to facilitate capture of healthcare processes that are activated independently, and sometimes well before, physiological changes are apparent.

10 December 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
SRSarah Collins Rossetti
Sarah Collins Rossetti
PDPatricia C Dykes
Patricia C Dykes
CKChristopher Knaplund
Christopher Knaplund
MKMin-Jeoung Kang
Min-Jeoung Kang
KSKumiko Schnock
Kumiko Schnock
KCKenrick Cato
Kenrick Cato
Background: Every year, hundreds of thousands of inpatients die from cardiac arrest and sepsis, which could be avoided if those patients’ risk for deterioration were detected and timely interventions were initiated. Thus, a system is needed to convert real-time, raw patient data into consumable information that clinicians can utilize to identify patients at risk of deterioration and thus prevent mortality and improve patient health outcomes. The overarching goal of the COmmunicating Narrative Concerns Entered by Registered Nurses (CONCERN) study is to implement and evaluate an early warning score system that provides clinical decision support (CDS) in electronic health record systems. With a combination of machine learning and natural language processing, the CONCERN CDS utilizes nursing documentation patterns as indicators of nurses’ increased surveillance to predict when patients are at the risk of clinical deterioration. Objective: The objective of this cluster randomized pragmatic clinical trial is to evaluate the effectiveness and usability of the CONCERN CDS system at 2 different study sites. The specific aim is to decrease hospitalized patients’ negative health outcomes (in-hospital mortality, length of stay, cardiac arrest, unanticipated intensive care unit transfers, and 30-day hospital readmission rates). Methods: A multiple time-series intervention consisting of 3 phases will be performed through a 1-year period during the cluster randomized pragmatic clinical trial. Phase 1 evaluates the adoption of our algorithm through pilot and trial testing, phase 2 activates optimized versions of the CONCERN CDS based on experience from phase 1, and phase 3 will be a silent release mode where no CDS is viewable to the end user. The intervention deals with a series of processes from system release to evaluation. The system release includes CONCERN CDS implementation and user training. Then, a mixed methods approach will be used with end users to assess the system and clinician perspectives. Results: Data collection and analysis are expected to conclude by August 2022. Based on our previous work on CONCERN, we expect the system to have a positive impact on the mortality rate and length of stay. Conclusions: The CONCERN CDS will increase team-based situational awareness and shared understanding of patients predicted to be at risk for clinical deterioration in need of intervention to prevent mortality and associated harm. Trial Registration: ClinicalTrials.gov NCT03911687; https://clinicaltrials.gov/ct2/show/NCT03911687 International Registered Report Identifier (IRRID): DERR1-10.2196/30238